The Ledger

Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.

clear all ✕

why aren't all 11 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable

Insight
Singh: Healthcare platforms should replace carrier support numbers to drive engagement
“The second thing we really have to do is in that early stage of deploying that customer, we have to be great at understanding their data, creating those personalized recommendations, and then finding a way via both consumer-based marketing techniques as well a…”
Rajiv Singh Jan 2, 2019 ▶ 15:57 a16z Podcast | Scaling Healthcare
Assertion Supported
Singh: High-deductible health plans only temporarily reduce healthcare costs
“The unfortunate reality is, the consumers never, didn't really get smarter as a part of joining the healthcare system as an economic buyer, and costs would go down for a year, and then start to slowly but surely drift back up.”
Rajiv Singh Jan 2, 2019 ▶ 1:57 a16z Podcast | Scaling Healthcare
Assertion Not checkable as stated
Singh: Accolade cuts employer healthcare spending by 5% to 7% initially
“We're really attacking the entire volume of healthcare spend, and so, you know, we've seen cost savings in the first year, five to seven percent.”
Rajiv Singh Jan 2, 2019 ▶ 10:17 a16z Podcast | Scaling Healthcare
Assertion Not checkable as stated
Singh: Accolade saved 2.9% in first year on 100,000-member exchange population
“We just got our first set of data on a 100,000 member population. That's 2.9% savings in the first year.”
Rajiv Singh Jan 2, 2019 ▶ 11:01 a16z Podcast | Scaling Healthcare
Assertion Supported
Singh: Companies with as few as 200 employees are adopting self-insurance
“And, you know, the number of thousand employees used to be the boundary for employers to move to self-insured. That number's going lower and lower every year. The number of employers who are saying, hey, in this fully insured model, my carrier's not necessaril…”
Rajiv Singh Jan 2, 2019 ▶ 3:28 a16z Podcast | Scaling Healthcare
Disclosure
Singh: Accolade moved all customer contracts from shared savings to fixed fees
“We've, in fact, moved all of our agreements To take a percentage of our revenues on a fixed basis, but we do want to be aligned with the customer's needs, and so we do that by saying, we'll measure ourselves on engagement.”
Rajiv Singh Jan 2, 2019 ▶ 13:26 a16z Podcast | Scaling Healthcare
Prediction Not checkable as stated
Rajiv Singh: Value-based care transition will survive presidential administration changes
“Here's one thing we know, I believe, that the work that CMS is doing, the work the private sector is doing in terms of moving to value-based care, that's not going to stop.”
Rajiv Singh Jan 2, 2019 ▶ 6:34 a16z Podcast | The Business of Healthcare
Prediction Not checkable as stated
Rajiv Singh: Healthcare winners must focus on consumers, not just enterprise buyers
“The companies that will succeed will fundamentally serve someone who's not paying for their own healthcare, who's not their buyer, but when you lose track of that buyer, when you lose track of that consumer, you lose your way.”
Rajiv Singh Jan 2, 2019 ▶ 15:00 a16z Podcast | The Business of Healthcare
Assertion Supported
Rajiv Singh: Accolade uses a hybrid model combining PMPM fees with incentives
“We're a combination of that meaning we'll charge a PMPM fee with an incentive associated with outcomes.”
Rajiv Singh Jan 2, 2019 ▶ 17:04 a16z Podcast | The Business of Healthcare
Assertion Partly supported
Rajiv Singh: U.S. healthcare spending grew from 10% to 19% of GDP
“20 years ago, 25 years ago, healthcare was 10% of GDP. Today, it's 19% of GDP.”
Rajiv Singh Jan 2, 2019 ▶ 2:28 a16z Podcast | The Business of Healthcare
Disclosure
Rajiv Singh: Accolade proved value via 25,000-person actuarially matched pilot studies
“The first set of Accolade customers were all control versus pilot tests. Where we take a group of 25,000 people in a population and compare them to another 25,000 who the actuarial said looked exactly alike.”
Rajiv Singh Jan 2, 2019 ▶ 9:41 a16z Podcast | The Business of Healthcare
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.